[Peripheral concentrations and distribution of a combination of anti-infective agents (spiramycin-metronidazole) in diabetics].
D000890:Anti-Infective Agents / Q000378:metabolism*; D003814:Dentistry, Operative; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism* / Q000382:microbiology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000382:microbiology; D004338:Drug Combinations / Q000378:metabolism; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000378:metabolism*; D008297:Male; D008795:Metronidazole / Q000378:metabolism*; D008826:Microbial Sensitivity Tests; D011300:Preoperative Care; D015572:Spiramycin; D013997:Time Factors; D014018:Tissue Distribution
D000890:Anti-Infective Agents; D004338:Drug Combinations; D007933:Leucomycins; D008795:Metronidazole; D015572:Spiramycin; C039503:Rodogyl
Concentrations périphériques et distribution d'une association d'anti-infectieux (spiramycine-métronidazole) chez le diabétique.